Animal Medicine Market Growth, Share, Industry Trends, Covid-19 Impact, Forecast 2030

Animal Medicine Market - By Type of Animal, By Type, By Type of Prescription, By Route of Administration, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2030

Published: Aug-2022	Report ID: HLCA2205	Pages: 1 - 224	Formats^*:
Category : Healthcare

Global Animal Medicine Market Overview:

According to SPER Market Research, the Global Animal Medicine Market is estimated to reach USD 54.97 billion by 2030 with a CAGR of 7.1%. The industry for animal medicine consists of businesses that produce veterinary medicines such as veterinary vaccinations, veterinary antibiotics, and other veterinary pharmaceuticals, as well as businesses that provide medical feed additives and dietary feed additives.

Growing expanding markets, rising pet expenditures, rising illness prevalence, rising outbreaks of poultry diseases, and a lack of generic medications all contributed to expansion over the historical era. Lack of veterinarians, ignorance, incorrect medication usage, the expense of animal care, the rise in the use of fake vaccinations and medications, and strict laws all had a detrimental impact on development during that time.

The market for animal medicines is anticipated to be constrained by the growing concern of antibiotic resistance among animals. The capacity of a microorganism to survive the effects of an antibiotic that formerly could effectively treat an infection caused by the same kind of bacteria is known as antibiotic resistance in animals. Overuse of antibiotics may be the cause of this. China declared a ban on antibiotic usage in feeds starting in 2020 and a halt to the manufacturing of commercial feed containing pharmaceutical feed additives that promote growth as a response to the threat posed by antibiotic resistance.

Companies that produce veterinarian medicines are increasingly focused on super-combo parasiticide in the market for animal medicines. Before parasites damage animals, parasiticides are drugs that aid in their management. Companies invest in and produce combination parasiticides as a result of these products' greater efficiency and efficacy. Companies in the animal pharmaceutical industry are increasingly developing combination parasiticides that help treat fleas, heartworms, and common intestinal parasites more effectively.

Impact of COVID-19 on the Global Animal Medicine Market :

Each industry has been touched by COVID-19, without exception. The market for veterinary medications has also been impacted. The demand for veterinary vaccines has increased to some extent due to enhanced health facilities for animal husbandry and growing knowledge of immunization against illnesses that affect cattle. However, amid the veterinary vaccination crisis, major players, governmental agencies, and healthcare organizations are collaborating closely with medical experts, clients, and patients to improve animal health.

Scope of the report:

Report Metric	Details
Market size available for years	2019-2030
Base year considered	2021
Forecast period	2022-2030
Segments covered	By Type of Animal, By Type, By Type of Prescription, By Route of Administration, By Distribution Channel
Geographies covered	North America, Europe, Asia Pacific, Latin America, Middle East, Africa
Companies Covered	Animalcare, Agrovet Market Animal Health, BASF India Ltd., Bayer, Animal Health Cadila Vaccines Ltd., Bimeda, Boehringer Ingelheim GmbH, Ceva SantÃ© Animale, Century Vaccines Limited, Chemo Argentina, DBK Pharma S.A.E., Elanco Animal Health Incorporated, HIPRA, IDT Biologika, Interfeed , Jurox Pty Ltd, Kyoritsu Seiyaku Corporation, Merck Animal Health, MSD Animal Health, Nimrod Veterinary Products Ltd., Novartis Animal Health, Phibro Animal Health Corporation, Sanofi Animal Health Inc., UCBVET, Virbac RSA, Zoetis India.

Global Animal Medicine Market Segmentation:

By Type of Animal: Based on the Type of Animal, Global Animal Medicine Market is segmented as; Poultry, Cattle (Dairy and Meat Purposes) Dogs and Cats, Other Companion Animals, Other Farm Animals.

By Type: Based on the Type, Global Animal Medicine Market is segmented as; Veterinary Pharmaceuticals

(Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides) Feed Additives (Medical Feed Additives, Nutritional Feed Additives).

By Type of Prescription: Based on the Type of Prescription, Global Animal Medicine Market is segmented as; OTC, Prescription.

By Route of Administration: Based on the Route of Administration, Global Animal Medicine Market is segmented as; Oral, Intravenous Subcutaneous, Others.

By Distribution Channel: Based on the Distribution Channel, Global Animal Medicine Market is segmented as; Veterinary services, Online, Others.

By Region: The Global Animal Medicine Market is majorly driven by North America. During the projected period, North America is anticipated to have the quickest rate of growth in the worldwide Global Animal Medicine Market.

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1 Research data source

2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPERâ€™s internal database
2.1.4 Premium insight from KOLâ€™s

2.2 Market size estimation

2.2.1 Top-down and Bottom-up approach

2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis

4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges

4.2. COVID-19 Impacts of the Global Animal Medicine Market

5. Market variables and outlook

5.1. SWOT analysis

5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats

5.2. PESTEL analysis

5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape

5.3. PORTERâ€™S five forces analysis

5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry

5.4. Heat map analysis

6. Global Animal Medicine Market, By Type Of Animal, 2019-2030 (USD Million)

6.1. Poultry
6.2. Cattle (Dairy and Meat Purposes)
6.3. Dogs and Cats
6.4. Other Companion Animals
6.5. Other Farm Animals

7. Global Animal Medicine Market, By Type, 2019-2030 (USD Million)

7.1. Veterinary Pharmaceuticals

7.1.1. Veterinary Vaccines
7.1.2. Veterinary Antibiotics
7.1.3. Veterinary Parasiticides

7.2. Feed Additives

7.2.1. Medical Feed Additives
7.2.1. Nutritional Feed Additives

8. Global Animal Medicine Market, By Type of Prescription, 2019-2030 (USD Million)

8.1. OTC
8.2. Prescription

9. Global Animal Medicine Market, By Route of Administration, 2019-2030 (USD Million)

9.1. Oral
9.2. Intravenous
9.3. Subcutaneous
9.4. Others

10. Global Animal Medicine Market, By Distribution Channel, 2019-2030 (USD Million)

10.1. Veterinary Services
10.2. Online
10.3. Others

11. Global Animal Medicine Market, By Region, 2019-2030 (USD Million)

11.1. North America

11.1.1. United States
11.1.2. Canada
11.1.3. Mexico

11.2. Europe

11.2.1. Germany
11.2.2. United Kingdom
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe

11.3. Asia-Pacific

11.3.1. China
11.3.2. Japan
11.3.3. India
11.3.4. Australia
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific

11.4. South America

11.4.1. Brazil
11.4.2. Argentina
11.4.3. Rest of South America

11.5. Middle East & Africa

11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates

11.5.3. Rest of Middle East & Africa

12. Company Profiles

12.1. Animalcare

12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments

12.2. Agrovet Market Animal Health

12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments

12.3. BASF India Ltd.

12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments

12.4. Bayer Animal Health Cadila Vaccines Ltd.

12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments

12.5. Bimeda

12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments

12.6. Boehringer Ingelheim GmbH

12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments

12.7. Ceva SantÃ© Animale

12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments

12.8. Century Vaccines Limited

12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments

12.9. Chemo Argentina

12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments

12.10. DBK Pharma S.A.E.

12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments

12.11. Elanco Animal Health Incorporated

12.11.1. Company details
12.11.2. Financial outlook
12.11.3. Product summary
12.11.4. Recent developments

12.12. HIPRA

12.12.1. Company details
12.12.2. Financial outlook
12.12.3. Product summary
12.12.4. Recent developments

12.13. IDT Biologika

12.13.1. Company details
12.13.2. Financial outlook
12.13.3. Product summary
12.13.4. Recent developments

12.14. Interfeed

12.14.1. Company details
12.14.2. Financial outlook
12.14.3. Product summary
12.14.4. Recent developments

12.15. Jurox Pty Ltd

12.15.1. Company details
12.15.2. Financial outlook
12.15.3. Product summary
12.15.4. Recent development

12.16. Kyoritsu Seiyaku Corporation

12.16.1. Company details
12.16.2. Financial outlook
12.16.3. Product summary
12.16.4. Recent developments

12.17. Merck Animal Health

12.17.1. Company details
12.17.2. Financial outlook
12.17.3. Product summary
12.17.4. Recent developments

12.18. MSD Animal Health

12.18.1. Company details
12.18.2. Financial outlook
12.18.3. Product summary
12.18.4. Recent developments

12.19. Nimrod Veterinary Products Ltd.

12.19.1. Company details
12.19.2. Financial outlook
12.19.3. Product summary
12.19.4. Recent developments

12.20. Novartis Animal Health

12.20.1. Company details
12.20.2. Financial outlook
12.20.3. Product summary
12.20.4. Recent developments

12.21. Phibro Animal Health Corporation

12.21.1. Company details
12.21.2. Financial outlook
12.21.3. Product summary
12.21.4. Recent developments

12.22. Sanofi Animal Health Inc.

12.22.1. Company details
12.22.2. Financial outlook
12.22.3. Product summary
12.22.4. Recent developments

12.23. UCBVET

12.23.1. Company details
12.23.2. Financial outlook
12.23.3. Product summary
12.23.4. Recent developments

12.24. Virbac RSA

12.24.1. Company details
12.24.2. Financial outlook
12.24.3. Product summary
12.24.4. Recent developments

12.25. Zoetis India

12.25.1. Company details
12.25.2. Financial outlook
12.25.3. Product summary
12.25.4. Recent development

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1